Ellen Crepin

Use of Genetic Testing and Prophylactic Mastectomy and Oophorectomy in Women With Breast or Ovarian Cancer From Families With a <i>BRCA1</i> or <i>BRCA2</i> Mutation

Hanne Meijers-Heijboer, Cecile T.M. Brekelmans, Marian B. E. Menke‐Pluymers et al. · Journal of Clinical Oncology · 2003 · 119 citations

Medicine, Gynecology, Oncology +15

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

Roger L. Milne, Barbara Burwinkel, Kyriaki Michailidou et al. · Human Molecular Genetics · 2014 · 59 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Prevalence of the variant allele rs61764370 T&gt;G in the 3′UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families

Antoinette Hollestelle, Cory Pelletier, Maartje J. Hooning et al. · Breast Cancer Research and Treatment · 2010 · 34 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1/2 patients

Madeleine M.A. Tilanus‐Linthorst, Karina C.M. Bartels, Celina Alves et al. · Breast Cancer Research and Treatment · 2005 · 24 citations

Medicine, Oncology, Breast Oncology +11